Sonova Holding AG, CH0012549785

Sonova stock gains modestly as investors focus on recent earnings

Published on 09/21/2026 at 11:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonova stock rose around 0.4 percent on September 21, 2026, after a recent advance on the SIX Swiss Exchange. The latest quarterly and full-year figures remain the key reference points for investors in the hearing care specialist.

A photorealistic audiology examination scene showing a patient wearing large professional audiometry headphones seated in a sound booth, while an audiologist in a white coat operates a clinical control panel with an audiogram chart displayed on a monitor
Sonova CH0012549785: Fotorealistische Audiologie-Untersuchung mit Patient, Kopfhörern und Audiogramm-Bildschirm in moderner Klinik, Illustration mit AI erstellt.

Sonova stock (ISIN CH0012549785) was quoted at around 233.00 Swiss francs on the SIX Swiss Exchange on September 21, 2026, reflecting a gain of approximately 0.4 percent compared with the previous close, according to recent price data from SIX-focused portals.

Recent earnings underpin Sonova stock

Sonova Holding AG, a leading global provider of hearing care solutions, last reported audited figures for its most recent fiscal year, giving investors a detailed view of revenue, earnings and margins across its hearing instruments and cochlear implants segments. Historical data from company releases show that in a recent fiscal year Sonova generated revenue in the multi-billion Swiss franc range, with profitability supported by operating margins in the mid-teens percent area, according to information typically summarized on investor-relations pages operated by the company.

In the latest reported interim period, which ended within the past several quarters, Sonova disclosed that revenue continued to grow compared with the prior-year period and that adjusted earnings per share improved, reflecting higher volumes and a favorable product mix. Historical comparisons from these reports indicate that year-on-year revenue growth reached double-digit percent territory in some segments, while earnings growth outpaced sales, underlining operational leverage in the business.

Valuation and market context

With Sonova stock trading close to the low end of its recently observed intraday range around 233.00 Swiss francs as of September 21, 2026, the market is weighing the company’s earnings trajectory against broader sector and index moves. At this price level, Sonova’s equity value translates into a market capitalization in the several billion Swiss franc range, based on the number of shares outstanding typically reported in company filings.

Compared with historical peaks reached in earlier periods, the current quotation leaves Sonova shares below prior highs, giving investors potential upside if earnings and cash flow trends stay intact. A quantified view from past data shows that when Sonova previously reported revenue growth of more than 10 percent and an increase in operating profit of a similar magnitude, the stock traded at a notably higher price than 233.00 Swiss francs, implying that the current level is at a discount to those historical valuation points.

Stock price level and investor view

On September 21, 2026, Sonova stock was changing hands at approximately 233.00 Swiss francs on SIX, up around 0.4 percent from the prior close, with this level sitting below historical highs but underpinned by solid past earnings performance.

Sonova stock key data

  • Company: Sonova Holding AG
  • ISIN: CH0012549785
  • Ticker: SOON
  • Trading venue: SIX Swiss Exchange
  • Price (as of September 21, 2026): 233.00 CHF
  • Sector / Industry: Health Care / Medical Equipment
  • Index membership: SMI

More news and analyses on Sonova stock

Disclaimer...

en | CH0012549785 | SONOVA HOLDING AG | boerse | 70143156 | bgmi